Nicolas Gendron: From HIT to VITT
Nicolas Gendron, Research Fellow, Hematologist at Boston Children’s Hospital, shared a post on LinkedIn:
”From HIT to VITT-like syndromes: an overview of immune thrombocytopenias linked to anti-PF4 antibodies
Very pleased to announce the publication of our synthesis in La Revue du Praticien: “From heparin-induced thrombocytopenia to the emergence of immune thrombotic thrombocytopenia syndromes associated with anti-PF4 antibodies”
This work, carried out with Manon Jouffroy and David Smadja, traces the evolution of knowledge on thrombotic syndromes mediated by anti-PF4 antibodies, from HIT to the emergence of VITT (post-vaccine) and VITT-like (acute “infectious” or chronic, as we recently described in the NEJM Group).
We detail the pathophysiological, diagnostic and therapeutic aspects of these rare but important entities for the understanding of immunothrombosis mediated by anti-PF4 antibodies.”
Read the full article here.
Article: From heparin-induced thrombocytopenia to the emergence of immune thrombotic thrombocytopenia syndromes
Authors: Manon Jouffroy, David M. Smadja, Nicolas Gendron
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jun 6, 2026, 08:25Marina Tarunina: Engineered Platelets From Human iPSCs Support Haemostasis Without Thromboembolism
-
Jun 6, 2026, 08:21Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention
-
Jun 6, 2026, 08:10Vrinda Trivedi: Hematologic Emergencies and Anticoagulation Strategies Spotlighted at CCCES 2026
-
Jun 6, 2026, 08:02Krisstina Gowin: Could the Gut Microbiome Be the Missing Link in Hematology Outcomes?
-
Jun 6, 2026, 07:59Razan Awan: Large Cohort Study Questions Routine Use of Dual Antiplatelet Therapy After TAVI
-
Jun 6, 2026, 07:28Ahmed Dheyaa Al-Obaidi: Retrospective Study Highlights the Role of Transient Elastography in Pediatric Hepatic Fibrosis
-
Jun 6, 2026, 06:55Valeria Galetti: Understanding the Root Causes of Anemia in Madagascar
-
Jun 6, 2026, 06:45Abdulrahman Al-Mashdali: Emerging Role of Anti-CD38 Therapy in ITP
-
Jun 6, 2026, 06:20Pedro Gaspar: The Role of CD4⁺ T Cells in APS